Human Vaccines · 2009 · 27 citations · 6 references
Veterinary MedicineInfectious DiseasesPediatricsCost-effectiveness AnalysisHealth EconomicsImmunizationImmunization PolicyModel-based Economic EvaluationVaccinationVaccination PolicyVaccine EffectivenessVaccine PolicyCost-effectiveness Of VaccinationPediatric Catch-up VaccinationSocietal Perspective AnalysisUniversal VaccinesVaccination Policy For AdolescentsVaccination StrategiesVaricella VaccinationVaricella-zoster Vaccines
This study explores the effects of three different 2-dose varicella zoster virus (VZV) vaccination strategies in Switzerland. The EVITA model was used to assess clinical benefits and costs of strategies (1) vaccination of 11-15 year old adolescents with a negative or uncertain history for chickenpox, (2) universal vaccination of toddlers at age 1 to 2 years, and (3) strategy 2 plus catch-up vaccination of 11-15 year old susceptible adolescents. The cost-effectiveness analysis compares strategies 2 and 3 versus strategy 1 (current vaccination policy in Switzerland). Probabilities for clinical outcomes and medical resource utilization were derived from a real-world survey among Swiss pediatricians and general practitioners including 236 individuals with VZV infection, published information on varicella complications, and expert opinion. Costs of medical resource utilization represent official Swiss medical tariffs. The model predicts both universal childhood vaccination strategies to be more effective in reducing varicella disease burden compared to strategy 1. Economically, both universal childhood vaccination strategies with or without catch-up result in net savings from the societal perspective reflected by a benefit cost ratio (BCR) of 1.22 or 1.29, respectively. In contrast, the model predicts net costs from the payer perspective (BCR of 0.27 and 0.30, respectively). These economic findings are comparable to those reported from other similar evaluations. However, due to the recent recommendation for using a 2-dose varicella vaccination schedule, our economic results for Switzerland are somewhat less favorable than those for other country analyses in which a less expensive 1-dose vaccination regimen for toddlers has been studied.
6
The Epidemiology of Varicella and Its Complications
Peter W. Choo, James G. Donahue, JoAnn E. Manson et al. · The Journal of Infectious Diseases · 1995 · 364 citations
Population-Based Studies of Varicella Complications
H. A. Guess, Daniel D. Broughton, L. Joseph Melton et al. · PEDIATRICS · 1986 · 345 citations
Age-Specific Risks of Varicella Complications
Stephen R. Preblud · PEDIATRICS · 1981 · 208 citations